Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
president trump
8
×
biotech
life sciences
national
national blog main
national top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicare
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
pfizer
cancer
cancer immunotherapy
investing
novartis
roche
startups
abbvie
alexion pharmaceuticals
alzheimer's disease
biogen
What
drug
8
×
roundup
bio
prices
plan
today
alzheimer’s
annual
attention
biotech
patients
pharmaceutical
prescription
trump
acquisitions
administration
advantages
ahead
albert
ambien
american
announced
asco
assessed
attendees
away
bar
beneficial
biggest
biopharma
blueprint
blunt
bourla
bringing
brings
camp’s
cancer
cash
ceo
ceos
Language
unset
unknown
Current search:
drug
×
" president trump "
×
@slashgear.com
4 years ago
FDA issues blunt malaria drug warning after deaths in coronavirus trial
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More